These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 2338545)
1. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine. Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545 [TBL] [Abstract][Full Text] [Related]
2. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain. Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544 [TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237 [TBL] [Abstract][Full Text] [Related]
4. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. Robertson GS; Damsma G; Fibiger HC J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study. Alfonso M; Durán R; Campos F; Perez-Vences D; Faro LR; Arias B Neurochem Res; 2003 Oct; 28(10):1487-93. PubMed ID: 14570393 [TBL] [Abstract][Full Text] [Related]
6. Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Butcher SP; Liptrot J; Aburthnott GW Neurosci Lett; 1991 Jan; 122(2):245-8. PubMed ID: 1902922 [TBL] [Abstract][Full Text] [Related]
7. Direct observation of dopamine compartmentation in striatal nerve terminal by 'in vivo' measurement of the specific activity of released dopamine. Leviel V; Gobert A; Guibert B Brain Res; 1989 Oct; 499(2):205-13. PubMed ID: 2804675 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter. Faro LR; do Nascimento JL; Alfonso M; Durán R Neurochem Int; 2002 Apr; 40(5):455-65. PubMed ID: 11821154 [TBL] [Abstract][Full Text] [Related]
9. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release. Hoffmann IS; Talmaciu RK; Cubeddu LX J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676 [TBL] [Abstract][Full Text] [Related]
10. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [TBL] [Abstract][Full Text] [Related]
11. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. Santiago M; Westerink BH J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat. Santiago M; Westerink BH Neurochem Int; 1992 Mar; 20 Suppl():107S-110S. PubMed ID: 1365406 [TBL] [Abstract][Full Text] [Related]
13. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929 [TBL] [Abstract][Full Text] [Related]
14. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
15. Reserpine-insensitive dopamine release in the substantia nigra? Elverfors A; Nissbrandt H Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998 [TBL] [Abstract][Full Text] [Related]
16. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism. Tomiyama K; Noguchi M; Koshikawa N; Kobayashi M J Neurochem; 1993 May; 60(5):1690-5. PubMed ID: 8473891 [TBL] [Abstract][Full Text] [Related]
17. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro. Kelly E; Jenner P; Marsden CD J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157 [TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study. Harsing LG; Sershen H; Toth E; Hashim A; Ramacci MT; Lajtha A Eur J Pharmacol; 1992 Jul; 218(1):117-21. PubMed ID: 1397026 [TBL] [Abstract][Full Text] [Related]
19. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Biggs CS; Starr MS Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]